Two-protein signature of novel serological markers apolipoprotein-A2 and serum amyloid alpha predicts prognosis in patients with metastatic renal cell cancer and improves the currently used prognostic survival models
Titel:
Two-protein signature of novel serological markers apolipoprotein-A2 and serum amyloid alpha predicts prognosis in patients with metastatic renal cell cancer and improves the currently used prognostic survival models
Auteur:
Vermaat, J.S. van der Tweel, I. Mehra, N. Sleijfer, S. Haanen, J.B. Roodhart, J.M. Engwegen, J.Y. Korse, C.M. Langenberg, M.H. Kruit, W. Groenewegen, G. Giles, R.H. Schellens, J.H. Beijnen, J.H. Voest, E.E.